IRVINE, Calif., Oct. 17, 2007 (PRIME NEWSWIRE) -- "At some point you have to wonder when critical mass will occur; when a company's brand hits sufficient shelves nationwide that the buyer becomes aware enough to build an expectation that another store on another day will have their favorite beverage," stated SmallCap Sentinel analyst D.R. Clark. "Sweet Success (OTCBB:SWTS) seems intent on hitting this breakthrough point with GlucaSafe(tm) -- a functional health beverage developed to maintain healthy glucose levels, lower hypertension and cholesterol -- by expanding further yet into 140 total pharmacy and drug department outlets."
A comprehensive report focusing on beverage maker Sweet Success, and of interest to investors in Jones Soda Company (Nasdaq:JSDA), Cadbury Schweppes PLC (NYSE:CSG), and Leading Brands Inc. (Nasdaq:LBIX) has been published by financial courier StockUpTicks.com and is available free of charge to the investing public at http://stockupticks.com/profiles/5-2-07.html
"Tuesday's news by Sweet Success acknowledges that as the diabetes epidemic continues to gain strength that their flagship brand GlucaSafe will likely be the primary growth driver for the company's beverage line," Clark noted. "According to the American Diabetes Association, one out of three babies born in the U.S. will become diabetic. In addition, 50% of babies born to families of minority origin in the U.S. will become diabetic."
San Antonio-based Sweet Success Enterprises, Inc. acquired Nestle's original Sweet Success brand in 2002. Nestle generated revenue of $300,000,000 from Sweet Success beverages. The company has re-launched the product line-up to tap into the rapidly growing demand for convenient and nutritious functional beverages.
For more updates on this subject and more register at http://stockupticks.com/register.html
To have your company featured on StockUpTicks.com or SmallCap Sentinel please use the contact info below.
For more D.R. Clark views on the market visit www.ClarkReport.com
These statements have not been evaluated by the FDA. Sweet Success products are not intended to diagnose, treat, cure or prevent disease.
The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664
Statements herein contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SmallCap Sentinel/StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP isn't an investment advisor and this report isn't investment advice. MP has been paid 325,000 restricted shares by Sweet Success for preparation/distribution of this report and other advertising services over a six-month period. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding the subject company.